Kaempferol protects against propacetamol-induced acute liver injury through CYP2E1 inactivation, UGT1A1 activation, and attenuation of oxidative stress, inflammation and apoptosis in mice.

MLA

Tsai, Ming-Shiun, et al. “Kaempferol Protects against Propacetamol-Induced Acute Liver Injury through CYP2E1 Inactivation, UGT1A1 Activation, and Attenuation of Oxidative Stress, Inflammation and Apoptosis in Mice.” Toxicology Letters, vol. 290, June 2018, pp. 97–109. EBSCOhost, https://doi.org/10.1016/j.toxlet.2018.03.024.

APA

Tsai, M.-S., Wang, Y.-H., Lai, Y.-Y., Tsou, H.-K., Liou, G.-G., Ko, J.-L., & Wang, S.-H. (2018). Kaempferol protects against propacetamol-induced acute liver injury through CYP2E1 inactivation, UGT1A1 activation, and attenuation of oxidative stress, inflammation and apoptosis in mice. Toxicology Letters, 290, 97–109. https://doi.org/10.1016/j.toxlet.2018.03.024

Chicago

Tsai, Ming-Shiun, Ying-Han Wang, Yan-Yun Lai, Hsi-Kai Tsou, Gan-Guang Liou, Jiunn-Liang Ko, and Sue-Hong Wang. 2018. “Kaempferol Protects against Propacetamol-Induced Acute Liver Injury through CYP2E1 Inactivation, UGT1A1 Activation, and Attenuation of Oxidative Stress, Inflammation and Apoptosis in Mice.” Toxicology Letters 290 (June): 97–109. doi:10.1016/j.toxlet.2018.03.024.